Mutational profiles of myelodysplastic syndromes (MDS) have established that a relatively small number of genetic aberrations. including SF3B1 and SRSF2 spliceosome mutations. lead to specific phenotypes and prognostic subgrouping. We performed a multi-omics factor analysis (MOFA) on two published MDS cohorts of bone marrow mononuclear cells (BMMNCs) and CD34 + cells with three data m... https://pipingrockers.shop/product-category/homeopathics/